Volume: 43 Issue: 3
Year: 2023, Page: 850-854, Doi: https://doi.org/10.51248/.v43i3.2507
Introduction and Aim: Two major clinical forms of acute coronary syndrome (ACS) were categorized; acute myocardial infarction (MI) showing ST-segment elevation (STEMI) with ECG, the other non-ST-segment elevation (NSTEMI). This study was designed using a new generation of high sensitivity cardiac troponin T2 (hscTnT2) in patients with acute coronary syndrome to evaluate the diagnostic value and its efficacy in differentiation of STEMI from NSTEMI.
Materials and Methods: one hundred twenty (120) patients diagnosed to have ACS were included in the study. Apparently, sixty-four (64) healthy subjects were considered as control. ECG and body mass index (BMI) were performed. Blood analysis of levels of glucose, lipid profile and glutamic-oxaloacetic transaminase (GOT) were measured as well as estimated the human hscTnT2 concentrations by enzyme linked immunosorbent assay (ELISA).
Results: ACS patients (STEMI & NSTEMI) showed significant high levels (hscTnT2), Cholesterol, TG, HDL, GOT, FBS and VLDL compared to control. Furthermore, (hscTnT2) serum level in STEMI 225.95 ±120.66 ng/L is significantly higher (P value <0.001) than NSEMI 102.32 ± 58.542 ng/L. the discrimination efficacy of hscTnT2 to differentiating STEMI from NSTEMI is high with cut off value 90.3 ng/L with high sensitivity.
Conclusion: The use of new generations of high sensitivity troponin T aided to reduce the time for accurate diagnosis of acute MI to less than 2 hours. The hscTnT serum value was higher in STEMI than NSTEMI patients and shown to be positively correlated with the degree of cardiac damage in ACS patients. The level of hscTnT can be considered as good discriminating diagnostic biomarkers to differentiate STEMI from NSTEMI patients.
Keywords: High sensitivity troponin T2; Acute coronary syndrome; Ischemia; STEMI; NSTEMI
1. Shepard, D., Vanderzanden, A., Moran, A., Naghavi, M., Murray, C., Roth, G. Ischemic heart disease worldwide, 1990 to 2013: estimates from the global burden of disease study 2013. Circulation: cardiovascular quality and outcomes. 2015;8(4):455-456
2. Cantor, E.J., Jain, A.K., Knight, C. Definitions of acute coronary syndromes. Medicine. 2014;42(9):502-504.
3. Garg, P., Morris, P., Fazlanie, A.L., Vijayan, S., Dancso, B., Dastidar, A.G., et al., Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Internal and emergency medicine. 2017;12(2):147-155.
4. Balk, E.M., Ioannidis, J.P., Salem, D., Chew, P.W., Lau, J. Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis. Annals of emergency medicine. 2001;37(5):478-494.
5. Alpert, J.S., Antman, E., Apple, F., Armstrong, P., Bassand, J., De Luna, A., et al., Myocardial infarction redefined-A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology. 2000;36(3):959-969.
6. Mumma, B.E., Casey, S.D., Dang, R.K., Polen, M.K., Kaur, J.C., Rodrigo, J., et al., Diagnostic Reclassification by a High-Sensitivity Cardiac Troponin Assay. Annals of Emergency Medicine. 2020;76(5):566-579.
7. Ooi, D.S., Isotalo, P.A., Veinot, J.P. Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology. Clinical Chemistry. 2000;46(3):338-344.
8. Kavsak, P.A., Macrae, A.R., Lustig, V., Bhargava, R., Vandersluis, R., Palomaki, G.E., et al., The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. American Heart Journal. 2006;152(1):118-125.
9. Braunwald, E., Antman, E.M., Beasley, J.W., Califf, R.M., Cheitlin, M.D., Hochman, J.S., et al., ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). Journal of the American College of Cardiology. 2002;40(7):1366-1374.
10. Di Stefano, R., Di Bello, V., Barsotti, M.C., Grigoratos, C., Armani, C., Dell'omodarme, M., et al., Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models. Biomedicine & Pharmacotherapy. 2009;63(10):773-780.
11. Hussein, A.a.R., Issa, A.H., Al-Saffar, A.F. Role of Serum Osteopontin and Osteoprotegerin Levels in Diagnosis of Acute Coronary Syndrome and Its Subtypes. Indian Journal of Public Health Research & Development. 2019;10(5):371-376
12. Haider, D.G., Klemenz, T., Fiedler, G.M., Nakas, C.T., Exadaktylos, A.K., Leichtle, A.B. High sensitive cardiac troponin T: testing the test. International journal of cardiology. 2017;228:779-783.
13. Mueller, M., Celik, S., Biener, M., Vafaie, M., Schwoebel, K., Wollert, K., et al., Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome. Clinical Research in Cardiology. 2012;101(10):837-845.
14. Twerenbold, R., Boeddinghaus, J., Mueller, C. Update on high-sensitivity cardiac troponin in patients with suspected myocardial infarction. European Heart Journal Supplements. 2018;20(suppl_G):G2-G10.
15. Cervellin, G., Mattiuzzi, C., Bovo, C., Lippi, G. Diagnostic algorithms for acute coronary syndrome—is one better than another? Annals of translational medicine. 2016;4(10).
16. Boeddinghaus, J., Reichlin, T., Nestelberger, T., Twerenbold, R., Meili, Y., Wildi, K., et al., Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin. Clinical Research in Cardiology. 2017;106(6):457-467
17. Chaulin, A.M., Duplyakov, D.V. Biomarkers of acute myocardial infarction: diagnostic and prognostic value. Part 1. Journal of Clinical Practice. 2020;11(3):75-84.
18. Hammarsten, O., Mair, J., Möckel, M., Lindahl, B., Jaffe, A.S. Possible mechanisms behind cardiac troponin elevations. Biomarkers. 2018;23(8):725-734.
19. Hassan, A.K., Bergheanu, S.C., Hasan-Ali, H., San Liem, S., Van Der Laarse, A., Wolterbeek, R., et al., Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention. The American journal of cardiology. 2009;103(6):779-784.
20. Bergovec, M., Vrazic, H., Rajcan, I.S., Raguz, M., Stipcevic, M., Udovicic, M. Features and pathophysiology of acute coronary syndrome. Acta medica Croatica: casopis Hravatske akademije medicinskih znanosti. 2009;63(1):3-7.
21. Rosengren, A., Wallentin, L., Gitt, A.K., Behar, S., Battler, A., Hasdai, D. Sex, age, and clinical presentation of acute coronary syndromes. European Heart Journal. 2004;25(8):663-670.
22. Ndumele, C.E., Coresh, J., Lazo, M., Hoogeveen, R.C., Blumenthal, R.S., Folsom, A.R., et al., Obesity, subclinical myocardial injury, and incident heart failure. JACC: Heart Failure. 2014;2(6):600-607.
23. Wallace, T.W., Abdullah, S.M., Drazner, M.H., Das, S.R., Khera, A., Mcguire, D.K., et al., Prevalence and determinants of troponin T elevation in the general population. Circulation. 2006;113(16):1958-1965.
24. Gonzalez-Pacheco, H., Vargas-Barron, J., Vallejo, M., Pina-Reyna, Y., Altamirano-Castillo, A., Sanchez-Tapia, P., et al., Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease. Therapeutics and Clinical Risk Management. 2014;10:815.
25. Ralapanawa, U., Kumarasiri, P.V.R., Jayawickreme, K.P., Kumarihamy, P., Wijeratne, Y., Ekanayake, M., et al., Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka. BMC cardiovascular disorders. 2019;19(1):1-9.
Ali Abdul Rasool Hussein, Ali Abdulateef Hasan Al-bayati, Abdulkareem H. Issa. Evaluation of the diagnostic value and differentiation efficacy of high sensitivity cardiac troponin T2 (hscTnT2) for STEMI and NSTEMI Iraqi patients. Biomedicine: 2023; 43(3): 850-854